Top Markets
#1 Siren Siren +44.38%
#2 Full Moon Full Moon +19.75%
#3 Seeker Seeker +17.93%
#4 Wrapped NXM Wrapped NXM +12.24%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.95%
#6 Zora Zora +10.62%
#7 VVS Finance VVS Finance +10.06%
#8 Cryptopia Cryptopia +9.26%
#9 Helium Helium +9.03%
#10 Axelar Axelar +6.97%
Coin of the day
Siren Siren
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AgomAb Therapeutics N.V. American Depositary Shares AgomAb Therapeutics N.V. American Depositary Shares

AgomAb Therapeutics N.V. American Depositary Shares

AGMB
Classement en actions #11830
AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company... AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist. Its innovative pipeline features several promising candidates, including Ontunisertib (AGMB-129), an orally administered, gastrointestinal-restricted small molecule inhibitor targeting ALK5 or TGFßR1, designed to treat Fibrostenosing Crohn's disease and presently undergoing Phase 2a clinical trials. Also in development is AGMB-447, an inhaled small molecule that similarly inhibits ALK5 or TGFßR1, intended for idiopathic pulmonary fibrosis and currently in Phase 1 clinical studies. Furthermore, the company is advancing AGMB-101, a monoclonal antibody designed to mimic HGF. This agent exerts its effects through the agonism or stimulation of the MET receptor, having demonstrated both antifibrotic and regenerative capabilities in preclinical models. Established in 2017, AgomAb Therapeutics maintains its headquarters in Antwerp, Belgium.
Prix de l'action
$13.26
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$653.15M
Changement (1 jour)
-4.17%
Changement (1 an)
-
Pays
BE
Échange AgomAb Therapeutics N.V. American Depositary Shares (AGMB)

Catégorie

Healthcare
Historique des dividendes pour AgomAb Therapeutics N.V. American Depositary Shares (AGMB)
AgomAb Therapeutics N.V. American Depositary Shares (symbole boursier : AGMB) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour AgomAb Therapeutics N.V. American Depositary Shares (AGMB) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH